Four Steps That Actually Fix the Problem — Not Just the Pain.
Every step has one job: find the biological reason you hurt, then treat that. Expect weeks, not overnight. We measure bloodwork so we are not guessing.
AI Assessment & Pain Diagnosis
Deep Muscle & Joint Analysis
AI-powered muscle age & biomarker analysis
We run AI analysis and biomarker testing for muscle age, inflammation, and how you move. That is the map an MRI often never draws.
Expert Consultation & Personalized Plan
Custom Treatment Blueprint
Custom treatment blueprint
A pain clinician sits with your biomarker profile and writes a plan: what we treat, in what order, and over how many weeks. You leave knowing the timeline, not a slogan.
Natural Phyto-Molecular Therapy
Drug-Free, Natural Healing
Drug-free, natural healing
Plant-molecular therapy plus Movement RX. The job is to reverse muscle degeneration, not to numb the joint. Active treatment is usually 4–12 weeks.
Ongoing Care & Optimization
Keep the result after the pain eases
Keep the result after the pain eases
We re-test biomarkers and change the plan when the numbers change. That is how relief lasts after week 12, instead of fading when you stop coming in.
Real Numbers. Real Patients. Real Results.
We don't ask you to trust us blindly. These numbers come from 35 years of treating real patients — in Delhi, Kolkata, and Panchkula — many of whom came to us after being told surgery was their only option.
Scientific Evidence Base
The biomarkers measured in OPTM's diagnostic panel are grounded in peer-reviewed medical literature.
About the Bio-Musculo Index Methodology
The Bio-Musculo Index (BMI) is a proprietary multi-biomarker diagnostic panel developed by Dr. Apurba Ganguly (PhD Biochemistry, DSc, Post-Doctorate Fellow) over 35+ years of clinical research. It aggregates individually validated blood biomarkers — including inflammatory cytokines, oxidative stress markers, cartilage degradation indicators, and metabolic parameters — into a composite AI-assisted index. Dr. Ganguly's own peer-reviewed publications (indexed on NIH/PubMed, ResearchGate, IABCR, and Longdom Publishing) form the primary evidence base for this protocol.
All citations below are authored or co-authored by Dr. Apurba Ganguly — Founder & Chief Research Officer, OPTM Healthcare. View full publication list at ResearchGate or SciProfiles.
Molecular signatures of varicosity: Diagnostic insights from ten biomarker panels
Ganguly A, Ganguly Anondeep. (2025). Molecular signatures of varicosity: Diagnostic insights from ten biomarker panels. PubMed Central (NIH). PMC12694810.
View Publication →Relevance: Dr. Ganguly's 2025 NIH-indexed research on multi-biomarker diagnostic panels — the methodology used in OPTM's Bio-Musculo Index
Pain diagnostic protocol and topical phytotherapeutic treatment for osteoarthritic disorders and prevention
Ganguly A. Pain diagnostic protocol and topical phytotherapeutic treatment for osteoarthritic disorders and prevention. International Online Medical Council (IOMC) Proceedings.
View Publication →Relevance: Dr. Ganguly's clinical research on OPTM's pain diagnostic and phytotherapeutic treatment protocol for osteoarthritis
Efficacy of Phytotherapeutic Protocol for the Risk Factor Reduction in Musculoskeletal Degeneration: A Systematic Meta-Analysis
Ganguly A. (2024). Efficacy of Phytotherapeutic Protocol for the Risk Factor Reduction in Musculoskeletal Degeneration: A Systematic Meta-Analysis. International Archives of BioMedical and Clinical Research (IABCR), Vol. 10, Issue 1, Mar 2024.
View Publication →Relevance: Dr. Ganguly's peer-reviewed meta-analysis validating OPTM's phytotherapy protocol for musculoskeletal risk factor reduction